Could blood tests Fine-Tune a major cancer drug?
NCT ID NCT06195527
Summary
This study aims to see if closely monitoring the amount of a cancer drug (pembrolizumab) in a patient's blood can help doctors use it more effectively. It will involve 75 adults with non-small cell lung cancer who are already receiving this treatment. Researchers will check if specific drug levels are linked to better tumor control and fewer side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Angers University Hospital
RECRUITINGAngers, 49000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CH Le Mans
NOT_YET_RECRUITINGLe Mans, 53000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.